HTR7; HTR5A; DRD1; HCAR2; HTR2B; HTR1A; HTR6; | |
GAA; | |
TDP1; CDA; HKDC1; HPGD; USP2; | |
CA2; CA1; CA12; CA9; CA7; CA3; CA14; CA5B; CA5A; CA6; | |
MMP9; MMP1; MMP2; | |
CREBBP; | |
SLC28A1; SLC28A3; | |
HTT; LMNA; F3; MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Bromodomain | CREBBP | CREB-binding protein | Q92793 | CHEMBL5747 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | CDA | Cytidine deaminase | P32320 | CHEMBL4502 |
Enzyme_unclassified | HKDC1 | Putative hexokinase HKDC1 | Q2TB90 | CHEMBL1741200 |
Enzyme_unclassified | HPGD | 15-hydroxyprostaglandin dehydrogenase [NAD+] | P15428 | CHEMBL1293255 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0007210; serotonin receptor signaling pathway | 6.975E-10 | 1.266E-06 | HTR1A, HTR2B, HTR5A, HTR6, HTR7 |
BP | GO:0009987; cellular process | GO:0007198; adenylate cyclase-inhibiting serotonin receptor signaling pathway | 2.375E-08 | 2.722E-05 | HTR1A, HTR5A, HTR7 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.184E-07 | 1.121E-04 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.293E-06 | 1.005E-03 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008283; cell proliferation | GO:1904707; positive regulation of vascular smooth muscle cell proliferation | 8.935E-06 | 5.450E-03 | HPGD, MMP2, MMP9 |
BP | GO:0051179; localization | GO:1904823; purine nucleobase transmembrane transport | 1.012E-05 | 5.450E-03 | SLC28A1, SLC28A3 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 1.012E-05 | 5.450E-03 | CYP2D6, CYP3A4 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.012E-05 | 5.450E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015855; pyrimidine nucleobase transport | 1.012E-05 | 5.450E-03 | SLC28A1, SLC28A3 |
BP | Unclassified; | GO:0042310; vasoconstriction | 2.101E-05 | 9.735E-03 | HTR1A, HTR2B, HTR7 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 1.328E-03 | 1.115E-02 | GAA; HKDC1 |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 4.888E-03 | 3.158E-02 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 8.969E-03 | 4.185E-02 | CYP1A2 |
hsa00500 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 4.564E-03 | 3.158E-02 | GAA; HKDC1 |
hsa00524 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 8.969E-03 | 4.185E-02 | HKDC1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.240E-03 | 1.115E-02 | CYP1A2; CYP3A4 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 6.102E-03 | 3.417E-02 | CYP1A2; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.741E-24 | 1.463E-22 | CA12; CA1; CA3; CA5B; CA2; CA5A; CA7; CA6; CA9; CA14 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.055E-04 | 3.208E-03 | CYP2D6; CYP1A2; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.586E-04 | 3.103E-03 | CYP2D6; CYP1A2; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Irritable bowel syndrome | A09, K58, K59.1 | HTR2B |
C00-D49: Neoplasms | Cancer | C00-C96 | CA1; CA9; MMP9; MMP2 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Non-small-cell lung cancer | NA | MMP2 |
C00-D49: Neoplasms | Pancreatic cancer | C25 | MMP2; F3 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Ovarian cancer | C56 | MMP2 |
C00-D49: Neoplasms | Chronic myeloid leukemia | NA | CREBBP |